Janux Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.33	430.61	19.21	51.43	35.58
Short-Term Investments	914.23	594.57	324.82	275.59	339.38
Cash & Short-Term Investments	966.57	1,025	344.03	327.02	374.97
Cash Growth	-5.72%	197.99%	5.20%	-12.79%	4699.24%
Other Current Assets	9.32	8.49	5.21	5.42	2.05
Total Current Assets	975.89	1,034	349.24	332.44	377.02
Net Property, Plant & Equipment	22.25	24.15	27.84	29.37	1.6
Other Long-Term Assets	3.42	3.7	3.33	2.21	1.21
Total Assets	1,002	1,062	380.41	364.01	379.82
Accounts Payable	4.97	4.03	2.42	2.16	2.46
Accrued Expenses	17.63	11.68	7.39	8.18	3.78
Current Portion of Leases	2.39	1.75	1.52	0.76	0.19
Unearned Revenue	-	-	1.71	5.41	5.16
Other Current Liabilities	-	-	-	-	1.2
Total Current Liabilities	25	17.46	13.03	16.51	12.8
Long-Term Leases	19.75	21.28	23.03	24.54	-
Other Long-Term Liabilities	-	-	-	2.22	0.7
Total Long-Term Liabilities	19.75	21.28	23.03	26.76	0.7
Total Liabilities	44.74	38.74	36.06	43.27	13.5
Common Stock	0.06	0.06	0.05	0.04	0.04
Additional Paid-in Capital	1,304	1,258	512.4	432.7	413.97
Accumulated Other Comprehensive Income	2.16	4.32	0.67	-1.54	-0.27
Retained Earnings	-351.38	-237.76	-168.76	-110.47	-47.41
Total Common Shareholders' Equity	956.82	1,023	344.35	320.74	366.33
Shareholders' Equity	956.82	1,023	344.35	320.74	366.33
Total Liabilities & Equity	1,002	1,062	380.41	364.01	379.82
Total Debt	22.14	23.03	24.54	25.31	0.19
Net Cash (Debt)	944.43	1,002	319.49	301.71	374.77
Net Cash Growth	-5.76%	213.68%	5.89%	-19.50%	4696.76%
Net Cash Per Share	15.24	18.64	7.26	7.28	15.93
Book Value	956.82	1,023	344.35	320.74	366.33
Book Value Per Share	15.44	19.03	7.82	7.73	15.57
Tangible Book Value	956.82	1,023	344.35	320.74	366.33
Tangible Book Value Per Share	15.44	19.03	7.82	7.73	15.57

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q